# Post-fracture Medication and Mortality

> **NCT05366621** · — · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 216155 (actual)

## Conditions studied

- Osteoporosis
- Osteoporosis Fracture
- Drug Therapy
- Mortality
- Adherence, Medication

## Interventions

- **DRUG:** Anti-osteoporosis medications

## Key facts

- **NCT ID:** NCT05366621
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-31
- **Target enrollment:** 216155 (ACTUAL)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05366621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05366621, "Post-fracture Medication and Mortality". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05366621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*